Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arnab Chatterjee

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Molecular Therapy. Nucleic Acids|October 8, 2024
Inhibition of SARS-CoV-2 growth in the lungs of mice by a peptide-conjugated morpholino oligomer targeting viral RNAAlexandra Sakai, Gagandeep Singh, Mahsa Khoshbakht, et al.
Cell Reports|July 6, 2026
Plasmodium falciparum HSP90 inhibitors show divergent resistance despite a shared ATP-binding siteFu-Hsuan Ko, Amanda K Lukens, Mariana Laureano de Souza, et al.
ACS Chemical Biology|April 17, 2012
A high-throughput screen to identify inhibitors of ATP homeostasis in non-replicating Mycobacterium tuberculosisPuiying A Mak, Srinivasa P S Rao, Mai Ping Tan, et al.
PNAS Nexus|March 26, 2024
A small molecule MST1/2 inhibitor accelerates murine liver regeneration with improved survival in models of steatohepatitisRyan Watkins, Ana Gamo, Seung Hyuk Choi, et al.
Nature Communications|November 26, 2014
Pyrazoleamide compounds are potent antimalarials that target Na+ homeostasis in intraerythrocytic Plasmodium falciparumAkhil B Vaidya, Joanne M Morrisey, Zhongsheng Zhang, et al.
Science (New York, N.Y.)|November 19, 2011
Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discoveryStephan Meister, David M Plouffe, Kelli L Kuhen, et al.
Nature Communications|October 27, 2010
A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacyKevin Pethe, Patricia C Sequeira, Sanjay Agarwalla, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Molecular Therapy. Nucleic Acids|October 8, 2024
Inhibition of SARS-CoV-2 growth in the lungs of mice by a peptide-conjugated morpholino oligomer targeting viral RNAAlexandra Sakai, Gagandeep Singh, Mahsa Khoshbakht, et al.
Cell Reports|July 6, 2026
Plasmodium falciparum HSP90 inhibitors show divergent resistance despite a shared ATP-binding siteFu-Hsuan Ko, Amanda K Lukens, Mariana Laureano de Souza, et al.
ACS Chemical Biology|April 17, 2012
A high-throughput screen to identify inhibitors of ATP homeostasis in non-replicating Mycobacterium tuberculosisPuiying A Mak, Srinivasa P S Rao, Mai Ping Tan, et al.
PNAS Nexus|March 26, 2024
A small molecule MST1/2 inhibitor accelerates murine liver regeneration with improved survival in models of steatohepatitisRyan Watkins, Ana Gamo, Seung Hyuk Choi, et al.
Nature Communications|November 26, 2014
Pyrazoleamide compounds are potent antimalarials that target Na+ homeostasis in intraerythrocytic Plasmodium falciparumAkhil B Vaidya, Joanne M Morrisey, Zhongsheng Zhang, et al.
Science (New York, N.Y.)|November 19, 2011
Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discoveryStephan Meister, David M Plouffe, Kelli L Kuhen, et al.
Nature Communications|October 27, 2010
A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacyKevin Pethe, Patricia C Sequeira, Sanjay Agarwalla, et al.
Pageof 6